AAAAAA
Results:
1-16
|
Results: 16
Authors:
Kulkarni, R
Aledort, LM
Berntorp, E
Brackman, HH
Brown, D
Cohen, AR
Ewing, NP
Gringeri, A
Gruppo, R
Hoots, K
Leissenger, C
Peerlinck, K
Poon, MC
Wong, WY
Citation: R. Kulkarni et al., Therapeutic choices for patients with hemophilia and high-titer inhibitors, AM J HEMAT, 67(4), 2001, pp. 240-246
Authors:
Santagostino, E
Morfini, M
Rocino, A
Baudo, F
Scaraggi, FA
Gringeri, A
Citation: E. Santagostino et al., Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors, THROMB HAEM, 86(4), 2001, pp. 954-958
Authors:
Gringeri, A
Citation: A. Gringeri, The Italian randomized evaluation of prophylaxis, HAEMOPHILIA, 6, 2000, pp. 19-19
Authors:
Gringeri, A
Citation: A. Gringeri, Towards a therapeutic and preventive anti-AIDS vaccine: defective nef alleles in a cohort of haemophiliacs with progressing and nonprogressing HIV-1 infection and safety and immunogenicity studies of anti-HIV-1 tat vaccine in HIV-1 positive patients and in healthy subjects, HAEMOPHILIA, 6, 2000, pp. 23-23
Authors:
Engelfriet, CP
Reesink, HW
Mannucci, PM
Gringeri, A
Ingerslev, J
Brettler, DB
Mauser-Bunschoten, EP
Negrier, C
Berntorp, E
Smith, OP
Shapiro, AD
Citation: Cp. Engelfriet et al., The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies, VOX SANGUIN, 78(4), 2000, pp. 256-261
Authors:
Brambilla, A
Villa, C
Rizzardi, G
Veglia, F
Ghezzi, S
Lazzarin, A
Cusini, M
Muratori, S
Santagostino, E
Gringeri, A
Louie, LG
Sheppard, HW
Poli, G
Michael, NL
Pantaleo, G
Vicenzi, E
Citation: A. Brambilla et al., Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection, J INFEC DIS, 182(1), 2000, pp. 311-315
Authors:
Gringeri, A
Musicco, M
Hermans, P
Bentwich, Z
Cusini, M
Bergamasco, A
Santagostino, E
Burny, A
Bizzini, B
Zagury, D
Citation: A. Gringeri et al., Active anti-interferon-alpha immunization: A European-Israeli, randomized,double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study), J ACQ IMM D, 20(4), 1999, pp. 358-370
Authors:
Gringeri, A
Santagostino, E
Muca-Perja, M
Le Buanec, H
Bizzini, B
Lachgar, A
Zagury, JF
Rappaport, J
Burny, A
Gallo, RC
Zagury, D
Citation: A. Gringeri et al., Tat toxoid as a component of a preventive vaccine in seronegative subjects, J ACQ IMM D, 20(4), 1999, pp. 371-375
Authors:
Zamarchi, R
Indraccolo, S
Minuzzo, S
Coppola, V
Gringeri, A
Santagostino, E
Vicenzi, E
De Silvestro, G
Biagiotti, R
Baldassarre, C
Chieco-Bianchi, L
Amadori, A
Citation: R. Zamarchi et al., Frequency of a mutated CCR-5 allele (Delta 32) among Italian healthy donors and individuals at risk of parenteral HIV infection, AIDS RES H, 15(4), 1999, pp. 337-344
Authors:
Beretta, A
Zanichelli, A
Agostoni, A
Cicardi, M
Gringeri, A
Citation: A. Beretta et al., C1 inhibitor function and anti-C1 inhibitor autoantibodies in patients with HIV type 1 infection, AIDS RES H, 15(1), 1999, pp. 95-96
Authors:
Bizzini, B
Volpato, I
Lachgar, A
Cohen, P
Gringeri, A
Citation: B. Bizzini et al., IFN alpha kinoid vaccine in conjunction with tritherapy, a weapon to combat immunopathogenesis in AIDS, BIOMED PHAR, 53(2), 1999, pp. 87-89
Authors:
Zagury, D
Lecoq, H
Gervi, I
Le Buanec, H
Zagury, JF
Bizzini, B
Burny, A
Hermans, P
Perja, M
Santagostino, E
Gringeri, A
Citation: D. Zagury et al., Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum - an adjuvant to antiretroviral tritherapy, BIOMED PHAR, 53(2), 1999, pp. 90-92
Authors:
Abrams, D
Allan, D
Antunes, F
Breckenridge, A
Bruun, J
Cameron, W
Carbon, C
Chalmers, I
Chang, H
Chodakewitz, J
Clendenin, N
Clumeck, N
Collier, A
Collins, G
Cooper, E
Cooper, D
Danner, S
D'Aquila, R
DeGruttola, V
DeMasi, R
Dee, L
Deyton, L
Dixon, D
Farthing, C
Feinberg, J
Fischl, M
Flepp, M
Gartland, M
Gatell, J
Gazzard, B
Goebel, F
Gotzsche, P
Gringeri, A
Hall, D
Hamilton, J
Hammer, S
Hartigan, P
Heath-Chiozzi, M
Henry, K
Hill, A
Hirschel, B
Ioannidis, J
Kahn, J
Katlama, C
Katzenstein, D
Killen, J
King, E
de Loes, SK
Kravcik, S
Lange, J
Leavitt, R
Leonard, J
Maeland, A
Mannucci, P
Mathiesen, L
McDade, H
Meibohn, A
Melander, H
Merigan, T
Mulder, J
Myers, M
Neaton, J
Nessling, M
Perrin, L
Pettinelli, C
Phair, J
Phillips, A
Pinching, A
Poppa, A
Power, L
Reiss, P
Richman, D
Rooney, J
Rousseau, F
Rutherford, G
Salgo, M
Sandstrom, E
Saravolatz, L
Savidge, G
Schnittman, S
Schooley, R
Seligmann, M
Simberkoff, M
Skowron, G
Slade, P
Smith, D
Smith, RP
Soriano, V
Stanley, K
Stingl, G
Stoffels, P
Struthers, L
Tierney, C
Thompson, M
Van der Broeck, R
Van Leeuven, R
Van Weverling, G
Veenstra, J
Vella, S
Volberding, P
Weber, J
Winslow, D
Yeni, P
Yeo, J
Dormont, J
Sande, M
Weller, I
Babiker, A
Collins, R
Darbyshire, J
Duncan, W
Foulkes, M
Hughes, M
Peto, R
Peto, T
Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025
Authors:
Brambilla, A
Turchetto, L
Gatti, A
Bovolenta, C
Veglia, F
Santagostino, E
Gringeri, A
Clementi, M
Poli, G
Bagnarelli, P
Vicenzi, E
Citation: A. Brambilla et al., Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection, VIROLOGY, 259(2), 1999, pp. 349-368
Authors:
Santagostino, E
Gringeri, A
Mannucci, PM
Citation: E. Santagostino et al., Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention, BR J HAEM, 104(1), 1999, pp. 22-26
Authors:
Le Buanec, H
Lachgar, A
Bizzini, B
Zagury, JF
Rappaport, J
Santagostino, E
Muca-Perja, M
Gringeri, A
Citation: H. Le Buanec et al., A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid, BIOMED PHAR, 52(10), 1998, pp. 431-435
Risultati:
1-16
|